Clinical Trials
5 trialsNCT02753309 2021-03-19
A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer
The University of Texas Health Science Center at San Antonio
Phase EARLY_PHASE1 Completed
NCT03298958 2019-06-12
Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer
The University of Texas Health Science Center at San Antonio
Phase 3 Withdrawn
NCT01938573 2017-10-20
Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer
University of Washington
Phase 1/2 Completed
NCT01522820 2016-10-04
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
Roswell Park Cancer Institute
Phase 1 Completed
NCT00375245 2014-01-17
Rapamycin With Grapefruit Juice for Advanced Malignancies
University of Chicago
Phase 1 Completed